Showing results (171-180 of 210) with videos related to
Sort By:
Pageof 21
Brain Pathology (Zurich, Switzerland)|November 3, 2020
Intracranial mesenchymal tumor with FET-CREB fusion-A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma-like neoplasmsEmily A Sloan, Jason Chiang, Javier E Villanueva-Meyer, et al.Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)Amar Gajjar, Giles W Robinson, Kyle S Smith, et al.Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.Acta Neuropathologica|January 27, 2016
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphologyIbrahim Qaddoumi, Wilda Orisme, Ji Wen, et al.The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.Nature Communications|April 9, 2014
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomesRobert Huether, Li Dong, Xiang Chen, et al.Acta Neuropathologica|August 18, 2022
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trialsAnthony P Y Liu, Sandeep K Dhanda, Tong Lin, et al.Cancer Cell|April 15, 2020
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasScott Ryall, Michal Zapotocky, Kohei Fukuoka, et al.Cancer Discovery|April 19, 2026
Therapy-related mutational signatures in subsequent neoplasms among survivors of childhood cancerSamuel W Brady, Michael A Arnold, Mingjuan Wang, et al.Pageof 21